Stock data
ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Inc. (PMN) reported net income of -US$39.72M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$40.17M | -US$39.72M | — |
| 2024 | — | — | -US$16.83M | US$2.78M | — |
| 2023 | — | — | -US$14.26M | -US$13.21M | — |
| 2022 | — | — | -US$23.38M | -US$18.06M | — |
| 2021 | — | — | -US$8.29M | -US$9.79M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$11.73M | — |
| 2026-03-31 | — | -US$8.24M | — |
| 2025-12-31 | — | -US$10.67M | — |
| 2025-09-30 | — | -US$11.58M | — |
| 2025-06-30 | — | -US$10.12M | — |
| 2025-03-31 | — | -US$7.35M | — |
| 2024-12-31 | — | -US$0.24M | — |
| 2024-09-30 | — | US$9.28M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.